Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.46 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.35 |
| ▸ | EDNRB | P24530 | 1/20 | 0.34 |
| ▸ | EDNRA | P25101 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | NQO2 | P16083 | 1/20 | 0.32 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28009925 | 0.89 | L3MBTL1 (0.52) | KDM4EATML3MBTL1ALOX5PTGER4 | |
| Benzene SCHEMBL21800968 | 0.88 | L3MBTL1 (0.53) | KDM4EATML3MBTL1ALOX5PTGER4 | |
| SCHEMBL9890872 | 0.88 | L3MBTL1 (0.53) | KDM4EATML3MBTL1ALOX5PTGER4 | |
| SCHEMBL18352325 | 0.87 | KDM4E (0.57) | KDM4EATML3MBTL1PTGER4EDNRB | |
| SCHEMBL18468317 | 0.85 | KDM4E (0.55) | KDM4EATML3MBTL1PTGER4EDNRB | |
| SCHEMBL23118787 | 0.85 | KDM4E (0.40) | KDM4EATML3MBTL1ALOX5PTGER4 | |
| SCHEMBL9890868 | 0.84 | ALOX5 (0.46) | KDM4EATML3MBTL1ALOX5EDNRB | |
| SCHEMBL21846226 | 0.84 | KDM4E (0.47) | KDM4EATML3MBTL1ALOX5PTGER4 | |
| SCHEMBL25658202 | 0.84 | L3MBTL1 (0.49) | KDM4EATML3MBTL1ALOX5PTGER4 | |
| SCHEMBL16521307 | 0.84 | L3MBTL1 (0.47) | KDM4EATML3MBTL1ALOX5PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8192847-B2 | Organic electroluminescent device material, organic electroluminescent device, display and illuminating device | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-06-05 | — | — | US | disclosed |
| US-8192847-B2 | Organic electroluminescent device material, organic electroluminescent device, display and illuminating device | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-06-05 | — | — | US | disclosed |
| US-20090167165-A1 | ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY AND ILLUMINATING DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090167165-A1 | ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY AND ILLUMINATING DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090167165-A1 | ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY AND ILLUMINATING DEVICE | L1CAM, OR10J3, ICOSLG | KDM4E 1687/4885ATM 3191/4885L3MBTL1 191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.